Listen to this article
The global healthcare sector is undergoing a profound transformation, one shaped by demographic pressures, rapid technological breakthroughs and shifting economic power centres. As populations age, chronic diseases proliferate and patients demand more personalised care, governments and investors alike are recalibrating priorities.
At the core of this shift are precision medicine, longevity science and artificial intelligence (AI)-powered diagnostics; a group of megatrends redefining what healthcare means. It is no longer just about treating illness, but rather extending healthy lifespans, enabling proactive wellness and harnessing data to predict problems before they emerge.
Precision medicine continues to accelerate as genetic sequencing becomes cheaper and more accessible. The cost of sequencing a genome, once millions of dollars, is now within reach for consumers and insurers, enabling clinicians to tailor treatment plans based on individual genetic profiles.
Oncology remains the leading application, but the approach is expanding into cardiology, neurology and autoimmune d
Continue Reading on Bangkok Post
This preview shows approximately 15% of the article. Read the full story on the publisher's website to support quality journalism.